Tumors that do not express estrogen receptors (ER), progesterone receptors (PR), and do not have HER2/Neu amplification are referred to as triple-negative breast cancers (TNBCs) [3]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.